Bone Biologics Corporation
BBLG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,112 | -$8,949 | -$1,485 | -$1,611 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $189 | $153 | $267 | $207 |
| Change in WC | -$150 | $133 | -$168 | -$320 |
| Other Non-Cash | -$51 | -$893 | -$2,181 | $496 |
| Operating Cash Flow | -$4,125 | -$9,556 | -$3,567 | -$1,229 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1,045 |
| Stock Issued | $2,616 | $5,044 | $4,430 | $6,859 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$3,213 | $0 | $0 | $0 |
| Other Fin. Act. | $5,020 | $0 | $0 | $0 |
| Financing Cash Flow | $4,423 | $5,044 | $4,430 | $7,904 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $299 | -$4,512 | $863 | $6,675 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,027 | $7,538 | $6,675 | $0 |
| End Cash | $3,325 | $3,027 | $7,538 | $6,675 |
| Free Cash Flow | -$4,125 | -$9,556 | -$3,567 | -$1,229 |